Yale University’s Procept Biorobotics PRCT Stock Holding History

Yale University’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-558,535	Closed	-$23.2M	–	5
2022 Q4	$23.2M	Buy	+558,535	New	+$24M	62.28%	1

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Yale University's PRCT Position: Q1 2023 in Review

Yale University sold out of Procept Biorobotics (PRCT) in Q1 2023, closing a stake of 558,535 shares — an estimated $23.2M sold.

Yale University first reported a position in PRCT in Q4 2022 and held it in 1 quarter. The position peaked at $23.2M in Q4 2022. 116 funds tracked by Wall St. Rank hold PRCT as of Q1 2023.

Yale University reported no remaining Procept Biorobotics position as of Q1 2023 after selling out during the quarter.
Yale University sold 558,535 Procept Biorobotics shares in Q1 2023, an estimated $23.2M.
Yale University first reported a position in Procept Biorobotics in Q4 2022 and held it in 1 quarter.
Yale University's Procept Biorobotics position peaked at $23.2M in Q4 2022.
116 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2023.

Based on Yale University's 13F filing for Q1 2023, filed 15 May 2023.